Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease

Yuanyuan Niu,Suling Liu,Qian Qiu,Di Fu,Youjun Xiao,Liuqin Liang,Yang Cui,Shanhui Ye,Hanshi Xu
DOI: https://doi.org/10.1186/s13075-024-03415-5
2024-10-29
Arthritis Research & Therapy
Abstract:Anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis (anti-MDA5-positvie DM) is a subtype of dermatomyositis with a poor prognosis, characterized by rapidly progressive interstitial lung disease (RP-ILD). The study aims to investigate the significance of serum cytokines profiles and peripheral lymphocytes in predicting prognoses of anti-MDA5-positvie DM with RP-ILD. Furthermore, it seeks to analyze longitudinal data of lymphocytes during hospitalization to identify distinct trajectories and cluster patients accordingly.
rheumatology
What problem does this paper attempt to address?